🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s FBRX Holdings & Trades

First Buy
Q4 2020
Duration Held
5 Quarters
Largest Add
Q4 2025
+487,275 Shares
Current Position
487,275 Shares
$13.29 M Value

Steven Cohen's FBRX Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 487,275 shares of Forte Biosciences, Inc. (FBRX) worth $13.29 M, representing 0.01% of the portfolio. First purchased in 2020-Q4, this short-term holding has been held for 5 quarters.

Based on 13F filings, Steven Cohen has maintained this position in FBRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 487,275 shares. Largest reduction occurred in Q3 2021, reducing 26,738 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Forte Biosciences (FBRX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Forte Biosciences (FBRX) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +487,275 New Buy 487,275 $27.27
Q3 2021 -26,738 Sold Out 0 $0.00
Q2 2021 +6,730 Add 33.64% 26,738 $840.49
Q1 2021 +16,608 Add 488.47% 20,008 $856.76
Q4 2020 +3,400 New Buy 3,400 $910.29

Steven Cohen's Forte Biosciences Investment FAQs

Steven Cohen first purchased Forte Biosciences, Inc. (FBRX) in Q4 2020, acquiring 3,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Forte Biosciences, Inc. (FBRX) for 5 quarters since Q4 2020.

Steven Cohen's largest addition to Forte Biosciences, Inc. (FBRX) was in Q4 2025, adding 487,275 shares worth $13.29 M.

According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 487,275 shares of Forte Biosciences, Inc. (FBRX), valued at approximately $13.29 M.

As of the Q4 2025 filing, Forte Biosciences, Inc. (FBRX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Forte Biosciences, Inc. (FBRX) was 487,275 shares, as reported at the end of Q4 2025.